Various resistance mechanisms to BV have been reported in cHL and ALCL cell lines, including increased expression of drug transporter proteins [96], auristatin E resistance [97] and release by HRS cells of CD30‐containing extracellular vesicles [98]. Here, TNFRSF8 is linked to classic Hodgkin lymphoma.